ArticleFrontiers in immunology2026
Camrelizumab-associated MG-like ocular neuromuscular toxicity after PD-1 inhibitor rechallenge in metastatic hepatocellular carcinoma: a case report with serial muscle injury-related biomarker changes.
Jie Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.